AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Director's Dealing 2013

Apr 2, 2013

5229_dirs_2013-04-02_d0ac5ebe-f1b9-4f19-965b-189a85c917ac.html

Director's Dealing

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3327B

AstraZeneca PLC

02 April 2013

Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 28 March 2013, Pascal Soriot, a Director of the Company notified us that, on 28 March 2013, he acquired an interest in 42,500 AstraZeneca PLC Ordinary Shares of $0.25 each at a price of 3292 pence per share.

Following this purchase, Mr Soriot has a total interest in 188,015 AstraZeneca shares.

A C N Kemp

Company Secretary

2 April 2013

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUUAAROOASRAR